Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATIONALE-15: PCV15 vs Placebo in Human Pneumococcal Challenge
NCT06731374Phase 4Recruiting
- Sponsor
- University of Oxford
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 15-valent conjugate vaccine in pneumococcal disease, sponsored by University of Oxford. Started Feb 2025; status: recruiting.
02
Drugs
pneumococcal 15-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT06731374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06731374.